Bayer Pharmaceuticals COO: The 2024 campaign is full of good intentions — and bad policy

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. You can also read Sandoz CEO Richard Saynor on what the 2024 conversation is missing.

The future of health care starts on Jan. 20, 2025. The stakes for Americans could not be higher.

Whether it’s Vice President Kamala Harris or former President Donald Trump in the White House that day, the health care industry must not lose sight of what matters most: giving all Americans more affordable access to the most innovative medicines.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Rise of RCM Managed Services: 95% of Healthcare Execs Embrace RCM Outsourcing

What You Should Know: – Ensemble Health Partners, a provider of revenue cycle management services, has released its 2024 Healthcare Business Trends Report, revealing a

December 9, 2023

AbbVie closes $8.7B Cerevel deal in bid to compete with Bristol Myers in schizophrenia

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 2, 2024

Protein marker unveiled for identifying blood vessel repair cells

Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels.

May 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.